Novartis AG
Patents, Design & Utilities
Last updated:
List of all Novartis AG patents 1,223 in total
| Status | Patent |
|---|---|
Application | Utility: CYCLODEXTRIN-BASED POLYMERS FOR DELIVERING THE THERAPEUTIC AGENTS COVALENTLY BOUND THERETO Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHODS OF TREATING ANKYLOSING SPONDYLITIS USING IL-17 ANTAGONISTS Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: Antiviral Pyrazolopyridinone Compounds Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHODS FOR TREATING DISEASE USING INHIBITORS OF BONE MORPHOGENETIC PROTEIN 6 (BMP6) Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Grant | Utility: Methods of enhancing immune response Filling date: 23 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Multifocal lens having reduced chromatic aberrations Filling date: 23 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Method for manufacturing toric contact lenses Filling date: 23 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: OCT-enabled injection for vitreoretinal surgery Filling date: 23 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Colored contact lens based on amorphous images Filling date: 23 Sep 2025 Issue date: 4 May 2021 |
Application | Utility: COMBINATION OF C-MET INHIBITOR WITH ANTIBODY MOLECULE TO PD-1 AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: REGULATORS OF HUMAN PLURIPOTENT STEM CELLS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: A TRIPLE PHARMACEUTICAL COMBINATION COMPRISING DABRAFENIB, TRAMETINIB AND AN ERK INHIBITOR Filling date: 23 Sep 2025 Issue date: 29 Apr 2021 |
Grant | Utility: Adaptive image registration for ophthalmic surgery Filling date: 23 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Surgical instrument having a surface texture Filling date: 23 Sep 2025 Issue date: 27 Apr 2021 |
Application | Utility: METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS Filling date: 23 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES Filling date: 23 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: Tablet Formulation of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Ylmethyl) Imidazo [1,2-B] [1,2,4] Triazin-2-YL] Benzamide Filling date: 23 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING LIGELIZUMAB Filling date: 23 Sep 2025 Issue date: 22 Apr 2021 |
Grant | Utility: Antibody molecules to TIM-3 and uses thereof Filling date: 23 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Manufacturing module for the manufacture of ophthalmic lenses Filling date: 23 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Methods for treating and/or reducing the likelihood of heart failure by administering anti-activin receptor type II (anti-ActRII) antibody Filling date: 23 Sep 2025 Issue date: 20 Apr 2021 |
Application | Utility: 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS Filling date: 23 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: LABEL-FREE ANALYSIS OF RNA CAPPING EFFICIENCY USING RNASE H, PROBES AND LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY Filling date: 23 Sep 2025 Issue date: 15 Apr 2021 |
Grant | Utility: Fused indazole pyridone compounds as antivirals Filling date: 23 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Site-specific chemoenzymatic protein modifications Filling date: 23 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Bis 2'-5'-RR-(3'F-A)(3'F-A) cyclic dinucleotide compound and uses thereof Filling date: 23 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: In vivo pre-surgical characterization of cataractous lenses Filling date: 23 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Therapeutic uses of a C-RAF inhibitor Filling date: 23 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Methods of reducing the risk of experiencing a cardiovascular (CV) event or a cerebrovascular event in a patient that has suffered a qualifying CV event Filling date: 23 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Systems and methods for tracking the orientation of surgical tools Filling date: 23 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Compounds and compositions for inhibiting the activity of SHP2 Filling date: 23 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Flavivirus replicons Filling date: 23 Sep 2025 Issue date: 13 Apr 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS Filling date: 23 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: Methods for Treating EGFR Mutant Cancers Filling date: 23 Sep 2025 Issue date: 8 Apr 2021 |
Grant | Utility: N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2 Filling date: 23 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Silicone hydrogel contact lenses Filling date: 23 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Methods of treating a crystal induced arthropathy using IL-1beta antibodies Filling date: 23 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Femtosecond laser docking apparatus Filling date: 23 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Dose and regimen for HDM2-p53 interaction inhibitors Filling date: 23 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Multidose inhaler Filling date: 23 Sep 2025 Issue date: 6 Apr 2021 |
Application | Utility: PROCESS FOR CONCENTRATION OF ANTIBODIES AND THERAPEUTIC PRODUCTS THEREOF Filling date: 23 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: Methods for Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Reduction Filling date: 23 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: USE OF MAVOGLURANT IN THE REDUCTION OF COCAINE USE OR IN PREVENTING RELAPSE INTO COCAINE USE Filling date: 23 Sep 2025 Issue date: 1 Apr 2021 |
Grant | Utility: Contact lenses with a lubricious coating thereon Filling date: 23 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: Refractive treatment of an eye by printing material onto a target Filling date: 23 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: Compositions and methods for treatment of diabetic retinopathy Filling date: 23 Sep 2025 Issue date: 30 Mar 2021 |
Application | Utility: DUAL-ACTING PHARMACEUTICAL COMPOSITIONS BASED ON SUPERSTRUCTURES OF ANGIOTENSIN RECEPTOR ANTAGONIST/BLOCKER (ARB) AND NEUTRAL ENDOPEPTIDASE (NEP) INHIBITOR Filling date: 23 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: Chemical Process for Preparing Imidazopyrrolidinone Derivatives and Intermediates Thereof Filling date: 23 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: REGULATABLE CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 25 Mar 2021 |
Showing 450 to 500 of 1223 patents.